Warning letter
DSP Skin Care LLC: warning letter of Jul 19, 2022
FDA warning letter 622549 · Division of Pharmaceutical Quality Operations IV
Key facts
| Reference number | 622549 |
|---|---|
| Company | DSP Skin Care LLC |
| Subject | CGMP/Finished Pharmaceuticals/Adulterated/Misbranded |
| Issue date | Jul 19, 2022 |
| Posted date | Aug 2, 2022 |
| Issuing office | Division of Pharmaceutical Quality Operations IV |
| Product type | Drugs |
| CFR sections cited | 201.66, 201.128, 207, 207.29, 207.41, 207.57, 211.22, 211.34, 330, 207.17(a), 211.165(a), 211.166(a) and 2 more |
| Inspection city | Los Angeles |
| Inspection ZIP | 90057 |
| Inspection start date | Sep 7, 2021 |
| Letter on fda.gov | fda.gov |
At a glance
- 10–99 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: